1. Todd, Dardas, Yanhong, Li, Shelby, D, et al. Incremental and independent value of cardiopulmonary exercise test measures and the Seattle Heart Failure Model for prediction of risk in patients with heart failure. J Heart Lung Transplant 2015; 34: 1017–1023.
Google Scholar | Crossref | Medline2. Koelling, TM1, Joseph, S, Aaronson, KD. Heart failure survival score continues to predict clinical outcomes in patients with heart failure receiving beta-blockers. J Heart Lung Transplant 2004; 23: 1414–1422.
Google Scholar | Crossref | Medline3. Agostoni, P, Corrà, U, Cattadori, G, et al.; MECKI Score Research Group . Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: A multiparametric approach to heart failure prognosis. Int J Cardiol 2013; 167: 2710–2718.
Google Scholar | Crossref | Medline | ISI4. Agostoni, P, Paolillo, S, Mapelli, M, et al. Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison. Eur J Heart Fail 2018; 20: 700–710.
Google Scholar | Crossref | Medline5. Magrì, D, Agostoni, P, Corrà, U, et al.; Metabolic Exercise test data combined with Cardiac and Kidney Indexes (MECKI) Score Research Group . Deceptive meaning of oxygen uptake measured at the anaerobic threshold in patients with systolic heart failure and atrial fibrillation. Eur J Prev Cardiol 2015; 22: 1046–1055.
Google Scholar | SAGE Journals | ISI6. Scrutinio, D, Agostoni, P, Gesualdo, L, et al.; Metabolic Exercise test data combined with Cardiac and Kidney Indexes (MECKI) Score Research Group . Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction. Circ J 2015; 79: 583–591.
Google Scholar | Crossref | Medline7. Rich, JD, Burns, J, Freed, BH, et al. Meta-Analysis Global Group in Chronic (MAGGIC) Heart Failure Risk Score: Validation of a simple tool for the prediction of morbidity and mortality in heart failure with preserved ejection fraction. J Am Heart Assoc 2018; 7: e009594.
Google Scholar | Crossref | Medline8. Ponikowski, P, Voors, AA, Anker, SD, et al.; ESC Scientific Document Group . 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016; 37: 2129–2200.
Google Scholar | Crossref | Medline | ISI9. Paolillo, S, Mapelli, M, Bonomi, A, et al. Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database. Eur J Heart Fail 2017; 19: 904–914.
Google Scholar | Crossref | Medline10. Fiuzat, M, Wojdyla, D, Pina, I, et al. Heart rate or beta-blocker dose? Association with outcomes in ambulatory heart failure patients with systolic dysfunction: Results from the HF-ACTION trial. JACC Heart Fail 2016; 4: 109–115.
Google Scholar | Crossref | Medline11. Ruwald, MH, Ruwald, AC, Jons, C, et al. Effect of metoprolol versus carvedilol on outcomes in MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy). J Am Coll Cardiol 2013; 61: 1518–1526.
Google Scholar | Crossref | Medline12. Ruiz, G, Andrey, JL, Puerto, JL, et al. Prognosis of heart failure with preserved ejection fraction treated with β-blockers: A propensity matched study in the community. Int J Cardiol 2016; 222: 594–602.
Google Scholar | Crossref | Medline13. Salvioni, E, Corrà, U, Piepoli, M, et al.; MECKI score research group . Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction. ESC Heart Fail 2020; 7: 371–380.
Google Scholar | Medline14. Cattadori, G, Agostoni, P, Corrà, U, et al.; MECKI score Research Group . Heart failure and anemia: Effects on prognostic variables. Eur J Intern Med 2017; 37: 56–63.
Google Scholar | Crossref | Medline15. Mehra, MR, Canter, CE, Hannan, MM, et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update. J Heart Lung Transplant 2016; 35: 1–23.
Google Scholar | Crossref | Medline | ISI16. Rovai, S, Corrà, U, Piepoli, M, et al.; MECKI Score Research Group . Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid-range ejection fraction. Eur J Heart Fail 2019; 21: 1586–1595.
Google Scholar | Crossref | Medline17. Kotecha, D, Manzano, L, Krum, H, et al.; Beta-Blockers in Heart Failure Collaborative Group . Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis. BMJ 2016; 353: i1855.
Google Scholar | Crossref | Medline18. García-Granja, PE, Dobarro, D, Tapia, C, et al. Mid-term beta-blocker treatment after low risk acute coronary syndrome. Eur J Prev Cardiol 2019; 26: 105–108.
Google Scholar | SAGE Journals | ISI19. Redondo-Bermejo, B, Pascual-Figal, DA, Hurtado-, Martinez JA, et al. Influence of gender on the clinical characteristics and prognosis of patients hospitalized for heart failure. Rev Esp Cardiol 2007; 60: 1135–1143.
Google Scholar | Crossref | Medline20. Eindhoven, DC, Hilt, AD, Zwaan, TC, et al. Age and gender differences in medical adherence after myocardial infarction: Women do not receive optimal treatment – The Netherlands claims database. Eur J Prev Cardiol 2018; 25: 181–189.
Google Scholar | SAGE Journals | ISI21. Corrà, U, Agostoni, P, Giordano, A, et al.; MECKI Score Research Group. Sex profile and risk assessment with cardiopulmonary exercise testing in heart failure: Propensity score matching for sex selection bias. Can J Cardiol 2016; 32: 754–759.
Google Scholar | Crossref | Medline22. Flather, MD, Shibata, MC, Coats, AJS, et al.; SENIORS Investigators . Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 2005; 26: 215–225.
Google Scholar | Crossref | Medline | ISI23. Carubelli, V, Metra, M, Corrà, U, et al.; MECKI Score Research Group . Exercise performance is a prognostic indicator in elderly patients with chronic heart failure – application of metabolic exercise cardiac kidney indexes score. Circ J 2015; 79: 2608–2615.
Google Scholar | Crossref | Medline24. Kotecha, D, Gill, SK, Flather, MD, et al. ; Beta-Blockers in Heart Failure Collaborative Group. Impact of renal impairment on beta-blocker efficacy in patients with heart failure. J Am Coll Cardiol 2019; 74: 2893–2904.
Google Scholar | Crossref | Medline25. Cattadori, G, Agostoni, P, Corrà, U, et al.; MECKI Score Research Group . Severe heart failure prognosis evaluation for transplant selection in the era of beta-blockers: Role of peak oxygen consumption. Int J Cardiol 2013; 168: 5078–5081.
Google Scholar | Crossref | Medline | ISI26. Nagatomo, Y, Yoshikawa, T, Okamoto, H, et al. Anemia is associated with blunted response to beta-blocker therapy using carvedilol – insight from Japanese Chronic Heart Failure Study. Circ J 2018; 82: 691–698.
Google Scholar | Crossref | Medline27. Crespo-Leiro, MG, Metra, M, Lund, LH, et al. Advanced heart failure: A position statement of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2018; 20: 1505–1535.
Google Scholar | Crossref | Medline28. Paolillo, S, Agostoni, P, Masarone, D, et al.; Metabolic Exercise test data combined with Cardiac and Kidney Indexes (MECKI) Score Research Group . Prognostic role of atrial fibrillation in patients affected by chronic heart failure. Data from the MECKI score research group. Eur J Intern Med 2015; 26: 515–520.
Google Scholar | Crossref | Medline29. Cleland, JGF, Bunting, KV, Flather, MD, et al.; Beta-blockers in Heart Failure Collaborative Group . Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: An individual patient-level analysis of double-blind randomized trials. Eur Heart J 2018; 39: 26–35.
Google Scholar | Crossref | Medline30. Nielsen, PB, Larsen, TB, Gorst-Rasmussen, A, et al. β-blockers in atrial fibrillation patients with or without heart failure: Association with mortality in a nationwide cohort study. Circ Heart Fail 2016; 9: e002597.
Google Scholar | Crossref | Medline | ISI31. Campodonico, J, Piepoli, M, Clemenza, F, et al.; MECKI Score Research Group . Dose-dependent efficacy of β-blocker in patients with chronic heart failure and atrial fibrillation. Int J Cardiol 2018; 273: 141–146.
Google Scholar | Crossref | Medline32. Cadrin-Tourigny, J, Shohoudi, A, Roy, D, et al. Decreased mortality with beta-blockers in patients with heart failure and coexisting atrial fibrillation: An AF-CHF substudy. JACC Heart Fail 2017; 5: 99–106.
Google Scholar | Crossref | Medline | ISI33. Weber, KT, Janicki, JS. Cardiopulmonary exercise testing for evaluation of chronic cardiac failure. Am J Cardiol 1985; 55: 22A–31A.
Google Scholar | Crossref | Medline | ISI34. Paolillo, S, Veglia, F, Salvioni, E, et al.; MECKI Score Research Group. Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years. Eur J Heart Fail 2019; 21: 208–217.
Google Scholar | Crossref | Medline35. Levy, WC, Dardas, TF. Comparison of cardiopulmonary-based risk models with a clinical heart failure risk model. Eur J Heart Fail 2018; 20: 711–714.
Google Scholar | Crossref | Medline